Promoter Aayush Agrawal, acting as the trustee for the Aayush Agrawal Trust, has created a pledge on 1,49,000 equity shares of Ajanta Pharma Limited. The stated reason for this encumbrance is to facilitate an increase in an existing loan. This disclosure, dated February 13, 2026, updates the holdings of several related promoter entities, showing a resulting encumbered stake of 6.60% in the company held by Bajaj Financial Securities Ltd as the beneficiary.
Disclosure of Share Encumbrance by Promoter
A formal disclosure was submitted by Aayush Agrawal, acting in his capacity as the Trustee for the Aayush Agrawal Trust, regarding the creation of a pledge on shares of Ajanta Pharma Limited. The event pertains to the pledge of 1,49,000 shares, which represents 0.12% of the total share capital as of the date of creation, February 11, 2026.
Reason for Pledge Creation
The stated purpose for this financial action is an ‘Increase the loan’. This move affects the holdings under the promoter group, impacting the previously encumbered position of the Aayush Agrawal Trust.
Updated Promoter Group Holdings Overview
The filing provides a snapshot of the shareholding structure for various promoter-related entities as of the reporting date, February 13, 2026. Key movements noted in the data include:
- Ravi P. Agrawal (Trustee Ravi Agrawal Trust): Held 13.00% of the total capital, with an existing encumbrance of 4.85% (60,63,920 shares).
- Aayush M. Agrawal (Trustee Aayush Agrawal Trust): Previously held 11.30%, with an existing encumbrance of 6.48% (80,99,407 shares). Following the creation of the new pledge, the resulting encumbered holding in favor of Bajaj Financial Securities Ltd stands at 6.60% (82,48,407 shares).
The document confirms that the required regulatory documentation detailing the creation of this pledge has been furnished to the stock exchanges and the company for their records.
Source: BSE
